76 related articles for article (PubMed ID: 19071009)
1. Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc.
Barman SK; Sen MK; Mahns DA; Wu MJ; Malladi CS
J Oncol; 2024; 2024():9925970. PubMed ID: 38249992
[TBL] [Abstract][Full Text] [Related]
2. The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems.
Rye MB; Krossa S; Hall M; van Mourik C; Bathen TF; Drabløs F; Tessem MB; Bertilsson H
iScience; 2022 Jun; 25(6):104451. PubMed ID: 35707723
[TBL] [Abstract][Full Text] [Related]
3. Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer.
Kocdor H; Ates H; Aydin S; Cehreli R; Soyarat F; Kemanli P; Harmanci D; Cengiz H; Kocdor MA
Drug Des Devel Ther; 2015; 9():3899-909. PubMed ID: 26251569
[TBL] [Abstract][Full Text] [Related]
4. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HS; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Hasmad HN; Berchuck A; ; ; Iversen ES; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
PLoS One; 2015; 10(6):e0128106. PubMed ID: 26091520
[TBL] [Abstract][Full Text] [Related]
5. Texaphyrins and water-soluble zinc(II) ionophores: development, mechanism of anticancer activity, and synergistic effects.
Preihs C; Magda DJ; Sessler JL
Bioinorg React Mech; 2013 Dec; 9(1-4):3-14. PubMed ID: 25295224
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles.
Tuomela S; Autio R; Buerki-Thurnherr T; Arslan O; Kunzmann A; Andersson-Willman B; Wick P; Mathur S; Scheynius A; Krug HF; Fadeel B; Lahesmaa R
PLoS One; 2013; 8(7):e68415. PubMed ID: 23894303
[TBL] [Abstract][Full Text] [Related]
7. Modification of neurobehavioral effects of mercury by genetic polymorphisms of metallothionein in children.
Woods JS; Heyer NJ; Russo JE; Martin MD; Pillai PB; Farin FM
Neurotoxicol Teratol; 2013; 39():36-44. PubMed ID: 23827881
[TBL] [Abstract][Full Text] [Related]
8. An investigation of modifying effects of metallothionein single-nucleotide polymorphisms on the association between mercury exposure and biomarker levels.
Wang Y; Goodrich JM; Gillespie B; Werner R; Basu N; Franzblau A
Environ Health Perspect; 2012 Apr; 120(4):530-4. PubMed ID: 22233731
[TBL] [Abstract][Full Text] [Related]
9. Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells.
Costello LC; Fenselau CC; Franklin RB
J Inorg Biochem; 2011 May; 105(5):589-99. PubMed ID: 21440525
[TBL] [Abstract][Full Text] [Related]
10. Dynamic transcriptomic profiles of zebrafish gills in response to zinc supplementation.
Zheng D; Kille P; Feeney GP; Cunningham P; Handy RD; Hogstrand C
BMC Genomics; 2010 Oct; 11():553. PubMed ID: 20937081
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
Yamasaki M; Nomura T; Sato F; Mimata H
Oncol Rep; 2007 Nov; 18(5):1145-53. PubMed ID: 17914565
[TBL] [Abstract][Full Text] [Related]
12. Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma.
Gumulec J; Masarik M; Krizkova S; Adam V; Hubalek J; Hrabeta J; Eckschlager T; Stiborova M; Kizek R
Curr Med Chem; 2011; 18(33):5041-51. PubMed ID: 22050752
[TBL] [Abstract][Full Text] [Related]
13. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.
Costello LC; Franklin RB
Mol Cancer; 2006 May; 5():17. PubMed ID: 16700911
[TBL] [Abstract][Full Text] [Related]
14. Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study.
Lin SF; Wei H; Maeder D; Franklin RB; Feng P
J Nutr Biochem; 2009 Dec; 20(12):1000-12. PubMed ID: 19071009
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.
Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P
Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.
Yin H; Smith M; Glass J
Prostate; 2005 Feb; 62(3):209-16. PubMed ID: 15389791
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
